Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.
about
Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malariaAdverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection.Abacavir hypersensitivity reaction: an update.Short-term safety and tolerability of a once-daily fixed-dose abacavir-lamivudine combination versus twice-daily dosing of abacavir and lamivudine as separate components: findings from the ALOHA study.
P2860
Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.
@ast
Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.
@en
type
label
Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.
@ast
Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.
@en
prefLabel
Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.
@ast
Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.
@en
P2860
P356
P1476
Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.
@en
P2093
Albert M L Anderson
John A Bartlett
P2860
P304
P356
10.1586/14787210.3.6.871
P577
2005-12-01T00:00:00Z